4.2 Article

Do Variable Rates of Alcohol Drinking Alter the Ability to Use Transdermal Alcohol Monitors to Estimate Peak Breath Alcohol and Total Number of Drinks?

Journal

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
Volume 38, Issue 10, Pages 2517-2522

Publisher

WILEY-BLACKWELL
DOI: 10.1111/acer.12528

Keywords

Transdermal Alcohol Monitoring; Binge Drinking; Alcohol Abuse; Breath and Blood Alcohol Concentration

Funding

  1. National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health [R01AA14988]
  2. National Institute of Drug Abuse [T32DA031115]
  3. William and Marguerite Wurzbach Distinguished Professorship

Ask authors/readers for more resources

BackgroundTransdermal alcohol monitoring is a noninvasive method that continuously gathers transdermal alcohol concentrations (TAC) in real time; thus, its use is becoming increasingly more common in alcohol research. In previous studies, we developed models that use TAC data to estimate peak breath alcohol concentration (BrAC) and standard units consumed when the rate of consumption was tightly controlled. MethodsTwenty-two healthy participants aged 21 to 52 who reported consuming alcohol on 1 to 4days per week were recruited from the community. The final study sample included 11 men and 8 women. Both TAC and BrAC were monitored while each participant drank 1, 2, 3, 4, and 5 beers in the laboratory on 5 separate days. In contrast to previous studies, a self-paced alcohol administration procedure was used. ResultsWhile there was considerable variation in the times it took to consume each beer, key TAC parameters were not affected by pace of drinking. TAC data were then used in combination with the previously derived equations and estimated peak BrAC and standard units of alcohol consumed. ConclusionsTransdermal alcohol monitoring can be used to reliably estimate peak BrAC and standard number of units consumed regardless of the rate of consumption, further demonstrating its usefulness in clinical research.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, Research & Experimental

Isradipine enhancement of virtual reality cue exposure for smoking cessation: Rationale and study protocol for a double-blind randomized controlled trial

Santiago Papini, Cara C. Young, Catherine S. Gebhardt, Alex Perrone, Hitoshi Morikawa, Michael W. Otto, John D. Roache, Jasper A. J. Smits

CONTEMPORARY CLINICAL TRIALS (2020)

Letter Psychiatry

Continuous Ketamine Infusion for Pain as an Opportunity for Psychotherapy for PTSD: A Case Series of Ketamine-Enhanced Psychotherapy for PTSD and Pain (KEP-P2)

Benjamin M. Keizer, John D. Roache, John R. Jones, Ryan J. Kalpinski, John H. Porcerelli, John H. Krystal

PSYCHOTHERAPY AND PSYCHOSOMATICS (2020)

Article Clinical Neurology

Sleep problems in active duty military personnel seeking treatment for posttraumatic stress disorder: presence, change, and impact on outcomes

Daniel J. Taylor, Kristi E. Pruiksma, Willie Hale, Carmen P. McLean, Laurie J. Zandberg, Lily Brown, Jim Mintz, Stacey Young-McCaughan, Alan L. Peterson, Jeffrey S. Yarvis, Katherine A. Dondanville, Brett T. Litz, John Roache, Edna B. Foa

SLEEP (2020)

Article Clinical Neurology

Manage Emotions to Reduce Aggression A Pilot Study of a Brief Treatment to Help Veterans Reduce Impulsive Aggression

Shannon R. Miles, Thomas A. Kent, Melinda Stanley, Karin E. Thompson, Carla Sharp, Barbara L. Niles, Stacey Young-McCaughan, Jim Mintz, John D. Roache, Brett T. Litz, Willie J. Hale, Matthew S. Stanford, Terence M. Keane, Alan L. Peterson

JOURNAL OF NERVOUS AND MENTAL DISEASE (2020)

Article Substance Abuse

Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial

John D. Roache, Martina Pavlicova, Aimee Campbell, Tse-Hwei Choo, Michelle Peavy, Andrea S. Kermack, Edward V. Nunes, John Rotrosen

Summary: The study compared the effectiveness of extended-release naltrexone and buprenorphine-naloxone in reducing drinking in patients with opioid use disorder, finding both medications to be equally effective. However, the study was limited by low levels of comorbid alcohol use disorder or heavy drinking observed in the participants.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2021)

Article Medicine, Research & Experimental

STRONG STAR and the Consortium to Alleviate PTSD: Shaping the future of combat PTSD and related conditions in military and veteran populations

Alan L. Peterson, Stacey Young-McCaughan, John D. Roache, Jim Mintz, Brett T. Litz, Douglas E. Williamson, Patricia A. Resick, Edna B. Foa, Donald D. McGeary, Katherine A. Dondanville, Daniel J. Taylor, Jennifer Schuster Wachen, Peter T. Fox, Craig J. Bryan, Carmen P. McLean, Kristi E. Pruiksma, Jeffrey S. Yarvis, Barbara L. Niles, Chadi G. Abdallah, Lynnette A. Averill, Sudie E. Back, Monty T. Baker, Tabatha H. Blount, Adam M. Borah, Elisa V. Borah, Matthew S. Brock, Lily A. Brown, Matthew M. Burg, Jeffrey A. Cigrang, Bryann B. DeBeer, Ellen R. DeVoe, Brooke A. Fina, Julianne C. Flanagan, Steffany J. Fredman, Cubby L. Gardner, Robert R. Gatchel, Jeffrey L. Goodie, Ralitza Gueorguieva, Jay B. Higgs, Vanessa M. Jacoby, Kevin M. Kelly, John H. Krystal, M. Danet Lapiz-Bluhm, Argelio L. Lopez-Roca, Brian P. Marx, Douglas M. Maurer, Meghan E. McDevitt-Murphy, Cindy A. McGeary, Eric C. Meyer, Shannon R. Miles, Candice M. Monson, David A. Morilak, John C. Moring, Vincent Mysliwiec, Karin L. Nicholson, Sheila A. M. Rauch, David S. Riggs, Craig S. Rosen, M. David Rudd, Richard P. Schobitz, Christian C. Schrader, Antoinette M. Shinn, Paulo R. Shiroma, Denise M. Sloan, Stephen L. Stern, Randy Strong, Steven D. Vannoy, Keith A. Young, Terence M. Keane

Summary: The STRONG STAR Consortium and the Consortium to Alleviate PTSD are interdisciplinary and multi-institutional research consortia dedicated to combat-related PTSD. They have successfully gathered a critical mass of investigators and institutions, enabling significant advancements in the prevention and treatment of combat PTSD and related conditions.

CONTEMPORARY CLINICAL TRIALS (2021)

Article Neurosciences

Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial

Chadi G. Abdallah, John D. Roache, Ralitza Gueorguieva, Lynnette A. Averill, Stacey Young-McCaughan, Paulo R. Shiroma, Prerana Purohit, Antoinette Brundige, William Murff, Kyung-Heup Ahn, Mohamed A. Sherif, Eric J. Baltutis, Mohini Ranganathan, Deepak D'Souza, Brenda Martini, Steven M. Southwick, Ismene L. Petrakis, Rebecca R. Burson, Kevin B. Guthmiller, Argelio L. Lopez-Roca, Karl A. Lautenschlager, John P. McCallin, Matthew B. Hoch, Alexandar Timchenko, Sergio E. Souza, Charles E. Bryant, Jim Mintz, Brett T. Litz, Douglas E. Williamson, Terence M. Keane, Alan L. Peterson, John H. Krystal

Summary: This study examined the efficacy of intravenous ketamine doses in reducing symptoms of posttraumatic stress disorder (PTSD). The results showed that ketamine did not have a dose-related effect on PTSD symptoms, but the standard dose had rapid antidepressant effects.

NEUROPSYCHOPHARMACOLOGY (2022)

Article Criminology & Penology

Aggression and violent behavior in the military: Self-reported conflict tactics in a sample of service members and veterans seeking treatment for posttraumatic stress disorder

Casey L. Straud, Patricia A. Resick, Edna B. Foa, Sudie E. Back, Candice M. Monson, Carmen P. McLean, Julianne C. Flanagan, Jennifer Schuster Wachen, Chelsea J. McMahon, Bailee Schuhman, Sarah Zwetzig, Jeffrey S. Yarvis, Adam M. Borah, Christian C. Schrader, Allah-Fard M. Sharrieff, Richard P. Schobitz, John D. Roache, Brett T. Litz, Stacey Young-McCaughan, Jim Mintz, Terence M. Keane, Alan L. Peterson, S. T. R. O. N. G. S. T. A. R. Consortium STRONG STAR Consortium, Consortium ot Alleviate P. T. S. D. Consortium ot Alleviate PTSD

Summary: Irritability, angry outbursts, and aggression are common in individuals with posttraumatic stress disorder (PTSD), and the relationship between PTSD and aggression might be particularly relevant among military/veteran populations. A study on a large sample of treatment-seeking military service members and veterans revealed that psychological aggression was more prevalent than physical aggression among military personnel with PTSD.

AGGRESSION AND VIOLENT BEHAVIOR (2022)

Article Psychology, Clinical

The associations between posttraumatic stress disorder and delay discounting, future orientation, and reward availability: A behavioral economic model

Cecilia C. Olin, Meghan E. McDevitt-Murphy, James G. Murphy, Rebecca J. Zakarian, John D. Roache, Stacey Young-McCaughan, Brett T. Litz, Terence M. Keane, Alan L. Peterson

Summary: The theoretical framework of behavioral economics has recently been applied to posttraumatic stress disorder (PTSD), suggesting that the overvaluation of negatively reinforced avoidance behavior is due to deficits in environmental reward. In a study of military personnel/veterans who served combat deployments after September 11, 2001, it was found that PTSD severity was inversely related to environmental and hedonic reward availability as well as future orientation.

JOURNAL OF TRAUMATIC STRESS (2022)

Article Psychology, Clinical

Combining a stellate ganglion block with prolonged exposure therapy for posttraumatic stress disorder: A nonrandomized clinical trial

Alan L. Peterson, Casey L. Straud, Stacey Young-McCaughan, John P. McCallin, Matthew Hoch, Napoleon P. Roux, Lauren Koch, Jose Lara-Ruiz, John D. Roache, Jennifer M. Hein, Tabatha H. Blount

Summary: Prolonged exposure therapy (PE) is an effective treatment for posttraumatic stress disorder (PTSD) in active duty service members and veterans. However, PE is associated with high dropout rates, limited tolerability, and temporary symptom exacerbation. Stellate ganglion blocks (SGBs) are a new treatment that, when combined with trauma-focused psychotherapy, may enhance the outcomes of PTSD treatment. A nonrandomized clinical trial was conducted to evaluate the combined use of SGB and massed PE therapy for combat-related PTSD. The results showed promising effects in improving the tolerability of trauma-focused therapies, reducing symptom severity, and increasing PTSD remission rates.

JOURNAL OF TRAUMATIC STRESS (2022)

Article Substance Abuse

Effectiveness of contingency management using transdermal alcohol monitoring to reduce heavy drinking among driving while intoxicated (DWI) arrestees: A randomized controlled trial

Donald M. Dougherty, Tae-Joon Moon, Yuanyuan Liang, John D. Roache, Richard J. Lamb, Charles W. Mathias, Alexander M. Wasserman, Erin E. Wood, Nathalie Hill-Kapturczak

Summary: This study examines the effectiveness of a contingency management procedure using transdermal alcohol concentration monitoring to reduce drinking among DWI arrestees. The results show that the contingency effects on alcohol use are more pronounced among frequent and heavy alcohol users. However, for individuals already under court-mandated TAC monitoring, the contingency management procedure did not produce additional reductions in drinking.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2023)

Article Psychology, Clinical

The Impact of Hazardous Drinking Among Active Duty Military With Posttraumatic Stress Disorder: Does Cognitive Processing Therapy Format Matter?

Casey L. Straud, Katherine A. Dondanville, Willie J. Hale, Jennifer S. Wachen, Jim Mintz, Brett T. Litz, John D. Roache, Jeffrey S. Yarvis, Stacey Young-McCaughan, Alan L. Peterson, Patricia A. Resick

Summary: This study aimed to evaluate the impact of hazardous drinking and treatment format on PTSD symptom severity and alcohol misuse among military service members seeking CPT for PTSD. The results showed significant reductions in PTSD symptoms for individuals with co-occurring PTSD and alcohol use disorder, regardless of treatment format. However, some participants remained classified as hazardous drinkers after treatment, suggesting that integrated treatment may be beneficial for this population.

JOURNAL OF TRAUMATIC STRESS (2021)

Article Psychiatry

A Comparison of Cognitive Processing Therapy and Seeking Safety for the Treatment of Posttraumatic Stress Disorder in Veterans

Muhammad R. Baig, Shuang Ouyang, Emma Mata-Galan, Michael A. Dawes, John D. Roache

Summary: The study compared the outcomes of Seeking Safety (SS) and cognitive processing therapy (CPT) in veterans with PTSD in a specialty clinic of an urban VA medical center. It was found that significantly more veterans completed SS treatment, but patients who completed CPT treatment had significantly greater decreases in PCL scores. The results emphasize the need for alternative approaches to provide trauma-focused care for dually diagnosed patients without delay.

PSYCHIATRIC QUARTERLY (2021)

Article Communication

Social Support and the Rehabilitation of Alcohol-Impaired Drivers: Drinking Motives as Moderators

Tae-Joon Moon, Charles W. Mathias, Jillian Mullen, Tara E. Karns-Wright, Nathalie Hill-Kapturczak, John D. Roache, Donald M. Dougherty

Summary: The study found that Abstinence-Specific Social Support has a positive impact on motivating alcohol-impaired drivers to reduce alcohol use, while Coping and Social Motives have a negative impact. The influence of Abstinence-Specific Social Support on motivation to change alcohol use is greater among those with stronger Enhancement Motives.

HEALTH COMMUNICATION (2021)

Article Medicine, General & Internal

Quetiapine augmentation of prolonged exposure therapy in veterans with PTSD and a history of mild traumatic brain injury: design and methodology of a pilot study

Muhammad R. Baig, Robert D. Beck, Jennifer L. Wilson, Jennifer A. Lemmer, Adeel Meraj, Eric C. Meyer, Jim Mintz, Alan L. Peterson, John D. Roache

MILITARY MEDICAL RESEARCH (2020)

No Data Available